4 233

Cited 0 times in

Uterine artery embolization of large fibroids: comparative study of procedure with and without pretreatment gonadotropin-releasing hormone agonists

Authors
 Man Deuk Kim  ;  Myungsu Lee  ;  Mu Sook Lee  ;  Sung Il Park  ;  Jong Yun Won  ;  Do Yun Lee  ;  Kwang Hun Leee 
Citation
 AMERICAN JOURNAL OF ROENTGENOLOGY, Vol.199(2) : 441-446, 2012 
Journal Title
 AMERICAN JOURNAL OF ROENTGENOLOGY 
ISSN
 0361-803X 
Issue Date
2012
MeSH
Adult ; Case-Control Studies ; Female ; Gonadotropin-Releasing Hormone/agonists* ; Humans ; Leiomyoma/therapy* ; Magnetic Resonance Angiography ; Magnetic Resonance Imaging* ; Middle Aged ; Retrospective Studies ; Statistics, Nonparametric ; Treatment Outcome ; Uterine Artery Embolization/methods* ; Uterine Neoplasms/therapy*
Keywords
gonadotropin-releasing hormone agonists ; large fibroids ; leiomyoma ; uterine artery embolization ; uterus
Abstract
OBJECTIVE: The purpose of this study was to evaluate the safety of pretreatment with gonadotropin-releasing hormone (GnRH) agonists before uterine artery embolization (UAE) of large fibroids. MATERIALS AND METHODS: The cases of 40 patients with large fibroids (≥ 10 cm) were retrospectively analyzed. Among the 40 patients, 28 (control group) underwent UAE without pretreatment with GnRH agonists, and 12 (GnRH group) received GnRH agonists 1-5 times before UAE. MRI was used to assess necrosis of large fibroids and their volumes in both groups within 3 months after UAE. RESULTS: Complete necrosis of large fibroids after UAE was achieved in 39 of 40 patients (97.5%). Only one patient, who was in the control group, had incomplete necrosis of the predominant fibroid. When GnRH agonists were administered before UAE, the mean volume reduction rate of fibroids was 36.3%. The final mean volume reduction rates of the predominant fibroids and the uterus after UAE in the GnRH group were 56.5% (range, 38-79%) and 50.8% (range, 35-72%), significantly higher than the volume reduction rates of 35.1% (range, 7-65%) and 34.9% (range, 16-54%) in the control group (p < 0.001). Grade D complications were not seen in the GnRH group but occurred in four patients in the control group. CONCLUSION: Pretreatment with GnRH agonists before UAE of large fibroids was safe for patients with large fibroids and did not prevent performance of UAE.
Full Text
http://www.ajronline.org/doi/abs/10.2214/AJR.11.7220
DOI
22826410
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers
Yonsei Authors
Kim, Man Deuk(김만득) ORCID logo https://orcid.org/0000-0002-3575-5847
Park, Sung Il(박성일)
Won, Jong Yun(원종윤) ORCID logo https://orcid.org/0000-0002-8237-5628
Lee, Kwang Hun(이광훈)
Lee, Do Yun(이도연)
Lee, Myung Su(이명수)
Lee, Mu Sook(이무숙)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/89446
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse